Primary information |
---|
ID | 12760 |
Uniprot ID | Q5RAT2 |
Description | Stanniocalcin-2 (STC-2) |
Organism | Pongo abelii |
Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Ponginae; Pongo; Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) |
Subcellular Location | Secreted |
Developmental Stage | NA |
Similarity | Belongs to the stanniocalcin family. |
Tissue Specificity | NA |
Post Translational Modification | NA |
Function | Has an anti-hypocalcemic action on calcium and phosphate homeostasis. |
Length | 302 |
Molecular Weight | 33 |
Name | Stanniocalcin-2 |
Sequence | DATNPPEGPQDRSPQQKGRLSLQNTAEIQHCLVNAGDVGCGVFECFENNSSEIRGLHGICMTFLHNAGKFDAQGKSFIKDALKCKAHALRHRFGCISRKCPAIREMVFQLQRECYLKHDLCAAAQENTRVIVEMIHFKDLLLHEPYVDLVNLLLTCGEEVKEAITHSVQVQCEQNWGSLCSILSFCTSAIQRPPTAPPERQPQVDRTKLSRAHHGEAGHHLPEPSSRETGRGAKGERGSKSHPNAHARGRVGGLGAQGPSGSSEWEDEQSEYSDIRR |
Sequence map | 30-02 |
PDB ID | NA |
Drugpedia | NA |
Receptor | NA |
Domain | NA |
Pharmaceutical Use | NA
|